Johnson & Johnson - 49 Year Stock Price History | JNJ

Historical daily share price chart and data for Johnson & Johnson since 1970 adjusted for splits. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Johnson & Johnson as of March 19, 2019 is 138.44.
Johnson & Johnson Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 132.7355 126.9114 139.4100 124.8947 138.4400 7.99%
2018 130.3399 134.6696 146.8695 117.0848 128.2028 -5.14%
2017 123.9321 109.2263 138.2097 105.3792 135.1436 24.40%
2016 105.6799 92.1446 116.6480 87.8070 108.6323 15.32%
2015 90.1058 93.0759 96.5189 82.5989 94.1988 1.16%
2014 88.5894 78.8774 96.6379 75.0562 93.1204 17.34%
2013 73.2503 59.5776 82.8633 59.4935 79.3627 34.62%
2012 55.2784 53.4396 60.4603 51.0457 58.9552 10.83%
2011 50.6018 49.1671 54.1068 45.5372 53.1962 9.89%
2010 47.7566 48.8955 50.2994 43.8332 48.4079 -0.58%
2009 42.9929 44.3570 49.1072 34.3682 48.6914 11.28%
2008 46.7751 46.8810 52.4057 40.4662 43.7573 -7.77%
2007 44.9136 46.0536 48.6521 41.8579 47.4429 3.61%
2006 42.6398 41.7590 47.6548 38.4863 45.7900 12.44%
2005 43.3847 41.7916 46.3077 40.6816 40.7223 -3.36%
2004 36.7918 33.6649 42.3630 32.3991 42.1371 25.17%
2003 33.9672 35.4294 37.7182 31.6099 33.6649 -2.11%
2002 36.6488 37.0808 41.5000 26.6081 34.3920 -7.88%
2001 32.6047 31.7913 38.5147 26.0354 37.3334 13.97%
2000 27.6918 28.3972 32.7575 21.1762 32.7575 14.04%
1999 28.8108 25.1790 32.6818 23.4464 28.7237 12.46%
1998 22.7081 19.5552 27.1003 19.2366 25.5413 28.99%
1997 17.8096 14.7433 20.1202 14.7433 19.8016 34.31%
1996 14.2763 12.3003 15.9287 12.3003 14.7433 18.11%
1995 9.9680 7.8079 13.3587 7.7004 12.4828 59.14%
1994 6.5493 6.3270 7.9698 5.1706 7.8437 25.00%
1993 5.8006 6.7543 6.7543 4.9519 6.2752 -8.93%
1992 6.6739 7.5215 7.7983 5.8302 6.8907 -10.19%
1991 5.9593 4.6107 7.7393 4.3222 7.6723 62.34%
1990 4.0993 3.8626 4.7849 3.3543 4.7260 23.38%
1989 3.1956 2.6381 3.8303 2.6381 3.8303 42.63%
1988 2.5232 2.4044 2.7630 2.1657 2.6854 16.52%
1987 2.6338 2.0438 3.2028 1.9746 2.3047 15.79%
1986 1.9136 1.5401 2.2294 1.4175 1.9904 27.43%
1985 1.3049 1.0280 1.6253 1.0135 1.5620 49.85%
1984 0.9716 1.1396 1.1815 0.8008 1.0424 -8.53%
1983 1.2575 1.3480 1.3930 1.0942 1.1396 -15.66%
1982 1.0999 0.9735 1.3888 0.8690 1.3512 36.93%
1981 0.8963 0.8626 1.0097 0.7528 0.9868 14.54%
1980 0.6764 0.6447 0.8637 0.5624 0.8615 29.41%
1979 0.5973 0.6066 0.6720 0.5400 0.6657 10.49%
1978 0.6206 0.5994 0.7210 0.5297 0.6025 -1.78%
1977 0.5568 0.6117 0.6134 0.4930 0.6134 0.43%
1976 0.6720 0.6972 0.7446 0.5638 0.6108 -12.03%
1975 0.6851 0.6361 0.7624 0.5652 0.6943 12.02%
1974 0.7520 0.8498 0.9067 0.5743 0.6198 -27.71%
1973 0.9019 0.9728 0.9879 0.7946 0.8574 -13.21%
1972 0.8913 0.7372 0.9994 0.7155 0.9879 32.98%
1971 0.6406 0.4295 0.7457 0.4295 0.7429 73.74%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $371.421B $81.581B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $251.806B 14.10
Merck (MRK) United States $220.845B 18.87
Novartis AG (NVS) Switzerland $214.807B 18.27
Eli Lilly (LLY) United States $131.074B 22.77
Novo Nordisk (NVO) Denmark $127.625B 20.64
AbbVie (ABBV) United States $119.216B 10.22
Sanofi (SNY) France $113.215B 13.98
AstraZeneca (AZN) United Kingdom $108.585B 12.39
GlaxoSmithKline (GSK) United Kingdom $100.340B 13.18
Bristol-Myers Squibb (BMY) United States $80.981B 12.46